5-fluoro-2-hydroxy-4-[4-[4-methyl-2-(pyridin-2-ylmethoxymethyl)-1,3-thiazol-5-yl]-1,3-thiazol-2-yl]benzoic acid
C21H16FN3O4S2 — CID 162757298
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-fluoro-2-hydroxy-4-[4-[4-methyl-2-(pyridin-2-ylmethoxymethyl)-1,3-thiazol-5-yl]-1,3-thiazol-2-yl]benzoic acid
5-fluoro-2-hydroxy-4-[4-[4-methyl-2-(pyridin-2-ylmethoxymethyl)-1,3-thiazol-5-yl]-1,3-thiazol-2-yl]benzoic acid (PubChem CID 162757298) has the molecular formula C21H16FN3O4S2 and a molecular weight of 457.51 g/mol. Its IUPAC name is 5-fluoro-2-hydroxy-4-[4-[4-methyl-2-(pyridin-2-ylmethoxymethyl)-1,3-thiazol-5-yl]-1,3-thiazol-2-yl]benzoic acid.
Molecular Properties
| Compound Name | 5-fluoro-2-hydroxy-4-[4-[4-methyl-2-(pyridin-2-ylmethoxymethyl)-1,3-thiazol-5-yl]-1,3-thiazol-2-yl]benzoic acid |
|---|---|
| PubChem CID | 162757298 |
| Molecular Formula | C21H16FN3O4S2 |
| Molecular Weight | 457.51 g/mol |
| Exact Mass | 457.06 |
| IUPAC Name | 5-fluoro-2-hydroxy-4-[4-[4-methyl-2-(pyridin-2-ylmethoxymethyl)-1,3-thiazol-5-yl]-1,3-thiazol-2-yl]benzoic acid |
| SMILES | Cc1nc(COCc2ccccn2)sc1-c1csc(-c2cc(O)c(C(=O)O)cc2F)n1 |
| InChI | InChI=1S/C21H16FN3O4S2/c1-11-19(31-18(24-11)9-29-8-12-4-2-3-5-23-12)16-10-30-20(25-16)13-7-17(26)14(21(27)28)6-15(13)22/h2-7,10,26H,8-9H2,1H3,(H,27,28) |
| InChIKey | JAXKVRGWLSKQNG-UHFFFAOYSA-N |
| XLogP | 4.90 |
| TPSA | 105.43 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 457.51 |
| LogP ≤ 5 | 4.90 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162757298 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.